$INCR.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AEOLUS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AEOLUS PHARMACEUTICALS, INC.. Get notifications about new insider transactions in AEOLUS PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 01 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | L | 0.40 | 5,000 | 2,000 | 10,632,372 | 10.6 M to 10.6 M (+0.05 %) |
Oct 01 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | L | 0.45 | 5,000 | 2,250 | 10,627,372 | 10.6 M to 10.6 M (+0.05 %) |
Oct 01 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.43 | 15,000 | 6,500 | 10,647,372 | 10.6 M to 10.6 M (+0.14 %) |
Oct 01 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.40 | 5,000 | 2,000 | 10,632,372 | 10.6 M to 10.6 M (+0.05 %) |
Oct 01 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.45 | 5,000 | 2,250 | 10,627,372 | 10.6 M to 10.6 M (+0.05 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 10,000 | 3,900 | 10,622,372 | 10.6 M to 10.6 M (+0.09 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | L | 0.39 | 11,000 | 4,241 | 10,622,372 | 10.6 M to 10.6 M (+0.10 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 10,000 | 3,900 | 10,622,372 | 10.6 M to 10.6 M (+0.09 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 11,000 | 4,241 | 10,622,372 | 10.6 M to 10.6 M (+0.10 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.36 | 7,020 | 2,549 | 10,601,372 | 10.6 M to 10.6 M (+0.07 %) |
Sep 19 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.33 | 2,200 | 726 | 10,594,352 | 10.6 M to 10.6 M (+0.02 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | P | 0.50 | 250,000 | 125,000 | 250,000 | |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 1,000,000 | |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 1,000,000 | |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.36 | 7,020 | 2,549 | 10,601,372 | 10.6 M to 10.6 M (+0.07 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | L | 0.33 | 2,200 | 726 | 10,594,352 | 10.6 M to 10.6 M (+0.02 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.41 | 6,000 | 2,470 | 10,592,152 | 10.6 M to 10.6 M (+0.06 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.40 | 6,000 | 2,420 | 10,586,152 | 10.6 M to 10.6 M (+0.06 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.40 | 200 | 80 | 10,580,152 | 10.6 M to 10.6 M (0.00 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.35 | 16,100 | 5,695 | 10,579,952 | 10.6 M to 10.6 M (+0.15 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.36 | 4,000 | 1,440 | 10,563,852 | 10.6 M to 10.6 M (+0.04 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.46 | 20,000 | 9,200 | 10,559,852 | 10.5 M to 10.6 M (+0.19 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.47 | 50,000 | 23,300 | 10,539,852 | 10.5 M to 10.5 M (+0.48 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.48 | 15,100 | 7,248 | 10,489,852 | 10.5 M to 10.5 M (+0.14 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 5,000 | 1,900 | 10,474,752 | 10.5 M to 10.5 M (+0.05 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.37 | 10,000 | 3,700 | 10,469,752 | 10.5 M to 10.5 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.36 | 10,000 | 3,600 | 10,459,752 | 10.4 M to 10.5 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 20,000 | 7,600 | 10,449,752 | 10.4 M to 10.4 M (+0.19 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 10,000 | 3,800 | 10,429,752 | 10.4 M to 10.4 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 5,000 | 1,950 | 10,420 | 5.4 K to 10.4 K (+92.25 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 20,000 | 7,650 | 10,414,752 | 10.4 M to 10.4 M (+0.19 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.36 | 10,800 | 3,875 | 10,394,752 | 10.4 M to 10.4 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 5,000 | 1,950 | 10,383,952 | 10.4 M to 10.4 M (+0.05 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.40 | 1,100 | 435 | 10,378,952 | 10.4 M to 10.4 M (+0.01 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 7,000 | 2,735 | 10,377,852 | 10.4 M to 10.4 M (+0.07 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 1,000 | 390 | 10,370,852 | 10.4 M to 10.4 M (+0.01 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 6,100 | 2,379 | 10,369,852 | 10.4 M to 10.4 M (+0.06 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 10,000 | 3,900 | 10,363,752 | 10.4 M to 10.4 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 30,200 | 11,521 | 10,353,752 | 10.3 M to 10.4 M (+0.29 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 7,100 | 2,698 | 10,323,552 | 10.3 M to 10.3 M (+0.07 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.38 | 10,000 | 3,800 | 10,316,452 | 10.3 M to 10.3 M (+0.10 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 100 | 39 | 10,306,452 | 10.3 M to 10.3 M (0.00 %) |
Sep 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Buy | P | 0.39 | 2,020 | 778 | 10,306,352 | 10.3 M to 10.3 M (+0.02 %) |
Sep 10 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | P | 0.50 | 250,000 | 125,000 | 250,000 | |
Aug 20 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.41 | 6,000 | 2,470 | 10,592,152 | 10.6 M to 10.6 M (+0.06 %) |
Aug 20 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 6,000 | 2,420 | 10,586,152 | 10.6 M to 10.6 M (+0.06 %) |
Aug 20 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 200 | 80 | 10,580,152 | 10.6 M to 10.6 M (0.00 %) |
Aug 20 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.35 | 16,100 | 5,695 | 10,579,952 | 10.6 M to 10.6 M (+0.15 %) |
Aug 20 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.36 | 4,000 | 1,440 | 10,563,852 | 10.6 M to 10.6 M (+0.04 %) |
Aug 05 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | J | 0.50 | 1,000,000 | 500,000 | 1,000,000 | |
Aug 05 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Option Exercise | P | 0.50 | 1,000,000 | 500,000 | 1,000,000 | |
Aug 05 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 20,000 | 9,200 | 10,559,852 | 10.5 M to 10.6 M (+0.19 %) |
Jul 15 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS JOHN L | President and CEO | Option Exercise | A | 0.32 | 250,000 | 80,000 | 250,000 | |
Jul 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS MICHAEL P | Chief Financial Off ... | Option Exercise | A | 0.36 | 90,000 | 32,400 | 90,000 | |
Apr 17 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.47 | 50,000 | 23,300 | 10,539,852 | 10.5 M to 10.5 M (+0.48 %) |
Apr 07 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.48 | 15,100 | 7,248 | 10,489,852 | 10.5 M to 10.5 M (+0.14 %) |
Apr 07 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.38 | 5,000 | 1,900 | 10,474,752 | 10.5 M to 10.5 M (+0.05 %) |
Apr 07 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.37 | 10,000 | 3,700 | 10,469,752 | 10.5 M to 10.5 M (+0.10 %) |
Mar 25 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.36 | 10,000 | 3,600 | 10,459,752 | 10.4 M to 10.5 M (+0.10 %) |
Mar 25 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.38 | 20,000 | 7,600 | 10,449,752 | 10.4 M to 10.4 M (+0.19 %) |
Mar 25 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.38 | 10,000 | 3,800 | 10,429,752 | 10.4 M to 10.4 M (+0.10 %) |
Mar 03 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 1,100 | 435 | 10,378,952 | 10.4 M to 10.4 M (+0.01 %) |
Mar 03 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 7,000 | 2,735 | 10,377,852 | 10.4 M to 10.4 M (+0.07 %) |
Mar 03 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 1,000 | 390 | 10,370,852 | 10.4 M to 10.4 M (+0.01 %) |
Mar 03 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 6,100 | 2,379 | 10,369,852 | 10.4 M to 10.4 M (+0.06 %) |
Mar 03 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 10,000 | 3,900 | 10,363,752 | 10.4 M to 10.4 M (+0.10 %) |
Mar 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 5,000 | 1,950 | 10,419,752 | 10.4 M to 10.4 M (+0.05 %) |
Mar 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.38 | 20,000 | 7,650 | 10,414,752 | 10.4 M to 10.4 M (+0.19 %) |
Mar 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.36 | 10,800 | 3,875 | 10,394,752 | 10.4 M to 10.4 M (+0.10 %) |
Mar 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 5,000 | 1,950 | 10,383,952 | 10.4 M to 10.4 M (+0.05 %) |
Feb 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.38 | 30,200 | 11,521 | 10,353,752 | 10.3 M to 10.4 M (+0.29 %) |
Feb 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.38 | 7,100 | 2,698 | 10,323,552 | 10.3 M to 10.3 M (+0.07 %) |
Feb 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.38 | 10,000 | 3,800 | 10,316,452 | 10.3 M to 10.3 M (+0.10 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 100 | 39 | 10,306,452 | 10.3 M to 10.3 M (0.00 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 2,020 | 778 | 10,306,352 | 10.3 M to 10.3 M (+0.02 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 16,000 | 6,240 | 10,304,332 | 10.3 M to 10.3 M (+0.16 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 1,000 | 390 | 10,288,332 | 10.3 M to 10.3 M (+0.01 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 100 | 39 | 10,287,332 | 10.3 M to 10.3 M (0.00 %) |
Jan 31 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.39 | 20,000 | 7,800 | 10,287,232 | 10.3 M to 10.3 M (+0.19 %) |
Jan 22 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 33,229 | 12,976 | 10,267,232 | 10.2 M to 10.3 M (+0.32 %) |
Jan 14 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS MICHAEL P | Chief Financial Off ... | Option Exercise | A | 0.40 | 45,000 | 18,000 | 45,000 | |
Jan 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 20,000 | 7,800 | 10,234,003 | 10.2 M to 10.2 M (+0.20 %) |
Jan 08 2008 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 10,000 | 3,950 | 10,214,003 | 10.2 M to 10.2 M (+0.10 %) |
Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 10,000 | 3,900 | 10,204,003 | 10.2 M to 10.2 M (+0.10 %) |
Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 1,000 | 400 | 10,194,003 | 10.2 M to 10.2 M (+0.01 %) |
Dec 31 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 16,800 | 6,552 | 10,193,003 | 10.2 M to 10.2 M (+0.17 %) |
Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.38 | 7,000 | 2,670 | 10,176,203 | 10.2 M to 10.2 M (+0.07 %) |
Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.39 | 11,000 | 4,290 | 10,169,203 | 10.2 M to 10.2 M (+0.11 %) |
Dec 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 15,000 | 5,951 | 10,158,203 | 10.1 M to 10.2 M (+0.15 %) |
Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.43 | 20,000 | 8,650 | 10,143,203 | 10.1 M to 10.1 M (+0.20 %) |
Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 30,000 | 13,161 | 10,123,203 | 10.1 M to 10.1 M (+0.30 %) |
Dec 10 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 10,000 | 4,540 | 10,093,203 | 10.1 M to 10.1 M (+0.10 %) |
Dec 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 35,000 | 15,750 | 10,083,203 | 10 M to 10.1 M (+0.35 %) |
Dec 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 30,000 | 13,500 | 10,048,203 | 10 M to 10 M (+0.30 %) |
Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.41 | 35,000 | 14,452 | 10,018,203 | 10 M to 10 M (+0.35 %) |
Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 15,000 | 6,251 | 9,983,203 | 10 M to 10 M (+0.15 %) |
Nov 29 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 6,000 | 2,650 | 9,968,203 | 10 M to 10 M (+0.06 %) |
Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.43 | 15,100 | 6,553 | 9,962,203 | 9.9 M to 10 M (+0.15 %) |
Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 20,000 | 8,450 | 9,947,103 | 9.9 M to 9.9 M (+0.20 %) |
Nov 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 20,000 | 8,750 | 9,927,103 | 9.9 M to 9.9 M (+0.20 %) |
Nov 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.47 | 25,000 | 11,750 | 9,907,103 | 9.9 M to 9.9 M (+0.25 %) |
Nov 07 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.48 | 55,559 | 26,785 | 9,882,103 | 9.8 M to 9.9 M (+0.57 %) |
Nov 07 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 10,000 | 4,550 | 9,826,544 | 9.8 M to 9.8 M (+0.10 %) |
Nov 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 35,200 | 15,344 | 9,816,544 | 9.8 M to 9.8 M (+0.36 %) |
Nov 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 100 | 45 | 9,781,344 | 9.8 M to 9.8 M (0.00 %) |
Nov 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.45 | 19,800 | 8,886 | 9,781,244 | 9.8 M to 9.8 M (+0.20 %) |
Nov 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.47 | 5,000 | 2,350 | 9,761,444 | 9.8 M to 9.8 M (+0.05 %) |
Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.40 | 25,000 | 10,000 | 9,756,444 | 9.7 M to 9.8 M (+0.26 %) |
Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.41 | 31,100 | 12,689 | 9,731,444 | 9.7 M to 9.7 M (+0.32 %) |
Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.43 | 11,000 | 4,720 | 9,700,344 | 9.7 M to 9.7 M (+0.11 %) |
Oct 26 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.44 | 5,000 | 2,200 | 9,689,344 | 9.7 M to 9.7 M (+0.05 %) |
Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.44 | 27,500 | 12,100 | 9,684,344 | 9.7 M to 9.7 M (+0.28 %) |
Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.42 | 21,000 | 8,822 | 9,656,844 | 9.6 M to 9.7 M (+0.22 %) |
Oct 17 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.49 | 13,000 | 6,425 | 9,635,844 | 9.6 M to 9.6 M (+0.14 %) |
Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.48 | 4,000 | 1,924 | 9,622,844 | 9.6 M to 9.6 M (+0.04 %) |
Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 10,000 | 4,600 | 9,618,844 | 9.6 M to 9.6 M (+0.10 %) |
Oct 09 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 20,000 | 10,040 | 9,608,844 | 9.6 M to 9.6 M (+0.21 %) |
Oct 04 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.46 | 25,000 | 11,450 | 9,588,844 | 9.6 M to 9.6 M (+0.26 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.52 | 12,500 | 6,475 | 9,563,844 | 9.6 M to 9.6 M (+0.13 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 7,000 | 3,530 | 9,551,344 | 9.5 M to 9.6 M (+0.07 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.47 | 15,000 | 7,100 | 9,544,344 | 9.5 M to 9.5 M (+0.16 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.47 | 2,000 | 940 | 9,529,344 | 9.5 M to 9.5 M (+0.02 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.51 | 15,000 | 7,673 | 9,527,344 | 9.5 M to 9.5 M (+0.16 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.40 | 62 | 25 | 9,512,344 | 9.5 M to 9.5 M (0.00 %) |
Oct 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | L | 0.51 | 2,000 | 1,020 | 9,512,282 | 9.5 M to 9.5 M (+0.02 %) |
Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.51 | 10,000 | 5,050 | 9,510,282 | 9.5 M to 9.5 M (+0.11 %) |
Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.50 | 10,000 | 5,000 | 9,500,282 | 9.5 M to 9.5 M (+0.11 %) |
Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.59 | 10,000 | 5,850 | 9,490,282 | 9.5 M to 9.5 M (+0.11 %) |
Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.53 | 2,200 | 1,174 | 9,480,282 | 9.5 M to 9.5 M (+0.02 %) |
Aug 21 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.54 | 5,000 | 2,722 | 9,478,082 | 9.5 M to 9.5 M (+0.05 %) |
Aug 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | ALEXANDER ELAINE | EVP & Chief Medical ... | Option Exercise | A | 0.72 | 2,000 | 1,440 | 2,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | KUMAR AMIT | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS JOHN L | President and CEO | Buy | P | 0.55 | 5,000 | 2,750 | 30,000 | 25 K to 30 K (+20.00 %) |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Farah John M JR | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Suzdak Peter David | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Lewis Michael E | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Cavalier David | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | RALLIS CHRIS A | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 30 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Krivulka Joseph J | Director | Option Exercise | A | 0.55 | 30,000 | 16,500 | 30,000 | |
Jul 13 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS JOHN L | President and CEO | Option Exercise | A | 0.90 | 250,000 | 225,000 | 250,000 | |
Jul 12 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | MCMANUS MICHAEL P | Chief Financial Off ... | Option Exercise | A | 1.01 | 90,000 | 90,900 | 90,000 | |
Jul 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | ALEXANDER ELAINE | EVP & Chief Medical ... | Option Exercise | A | 0.86 | 2,000 | 1,720 | 2,000 | |
Jun 01 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | ALEXANDER ELAINE | EVP & Chief Medical ... | Option Exercise | A | 0.85 | 2,000 | 1,700 | 2,000 | |
May 03 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | ALEXANDER ELAINE | EVP & Chief Medical ... | Option Exercise | A | 1.19 | 2,000 | 2,380 | 2,000 | |
Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 1.04 | 25,000 | 26,045 | 9,164,754 | 9.1 M to 9.2 M (+0.27 %) |
Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.78 | 13,500 | 10,504 | 9,139,754 | 9.1 M to 9.1 M (+0.15 %) |
Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.78 | 10,000 | 7,825 | 9,126,254 | 9.1 M to 9.1 M (+0.11 %) |
Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.63 | 41,000 | 25,650 | 9,116,254 | 9.1 M to 9.1 M (+0.45 %) |
Apr 20 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | Xmark Opportunity Partners, LL ... | 10% Owner | Buy | P | 0.61 | 20,000 | 12,176 | 9,075,254 | 9.1 M to 9.1 M (+0.22 %) |
Apr 02 2007 | INCR.OB | AEOLUS PHARMACEUTI ... | ALEXANDER ELAINE | EVP & Chief Medical ... | Option Exercise | A | 0.69 | 2,000 | 1,380 | 2,000 |